MedTrace Logo

Behavioral Treatment of Adolescent Substance Use

NCT02063984 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2021-06-04

Study results available
· View outcomes & findings →

Summary

This study will continue research designed to improve treatment outcomes for adolescent substance use disorders by integrating neuroscience- and behaviorally-based treatments. In particular, this project will be the first to evaluate whether Working Memory Training can enhance cognitive function and reduce impulsive decision making to improve abstinence outcomes. In addition, an adaptive abstinence-based incentive program will be evaluated as a new method for intervening with those who do not respond to their first-line treatment.

Conditions

Interventions

BEHAVIORAL

Intensive Outpatient Treatment (IOP) + Contingency Management (CM)

Multiple group sessions weekly, one individual counseling session weekly with teen to review and discuss contingency management abstinence-based incentives

BEHAVIORAL

Working Memory Training

25 computer-delivered sessions of neurocognitive training

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Mountain Manor Treatment Center

    collaborator OTHER

  • University of Pennsylvania

    collaborator OTHER

  • Johns Hopkins University

    collaborator OTHER

  • Spectrum Youth and Family Services

    collaborator OTHER

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Alan J Budney, Ph.D · Dartmouth College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2018-02-28
Completion
2018-08-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02063984 on ClinicalTrials.gov